Media Summary: Jim Di Nunzio, PhD Merck & Co., Distinguished Scientist, Oral Solid Dosage Drug Product Development Chemical compound Habit Internal structure Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ...
Solid Dispersions To Address Crystallinity - Detailed Analysis & Overview
Jim Di Nunzio, PhD Merck & Co., Distinguished Scientist, Oral Solid Dosage Drug Product Development Chemical compound Habit Internal structure Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates Keep going! Check out the next lesson and practice what you're learning: ... Most new active pharmaceutical ingredients (APIs) exhibit a very low solubility in water, leading to an insufficient absorption in the ...
Webinar presented on September 28, 2023 The webinar will provide a brief overview of the IQ Consortium's Working Group on ...
